USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: Predictive criteria

Radiology

Volumn 246, Issue 3, 2008, Pages 804-811

  Lahaye, Max J ^a   Engelen, Sanne M E ^a   Kessels, Alfons G H ^a   De Bruïne, Adriaan P ^a,b   Von Meyenfeldt, Maarten F ^a   Van Engelshoven, Jos M A ^a   Van De Velde, Cornelis J H ^c   Beets, Geerard L ^a   Beets Tan, Regina G H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leiden University Medical Center ^*  (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFORMED CONSENT; INSTITUTIONAL REVIEW; LYMPH NODE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; SEX DIFFERENCE; THREE DIMENSIONAL IMAGING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; ROC CURVE;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CONTRAST MEDIA; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDES; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; ROC CURVE;

EID: 40949106842     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2463070221     Document Type: Article

References (21)

1. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996;83:293-304.
2. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990;211:187-195.
3. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
4. Moran MR, James EC, Rothenberger DA, Goldberg SM. Prognostic value of positive lymph nodes in rectal cancer. Dis Colon Rectum 1992;35:579-581.
5. Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999;23:721-726.
6. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 2005;26:259-268.
7. Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a metaanalysis. Lancet Oncol 2006;7:52-60.
8. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
9. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001;19:1976-1984.
10. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493.
11. Frija G, Clement O, Le Guen O, Cuenod CA, Siauve N, Benderbous S. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes. Acad Radiol 1996;3(suppl 2):S299-S300.
12. Heald RJ. A new approach to rectal cancer. Br J Hosp Med 1979;22:277-281.
13. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
14. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213-230.
15. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428.
16. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
17. Koh DM, Brown G, Temple L, et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 2004;231:91-99.
18. Harisinghani MG, Saini S, Slater GJ, Schnall MD, Rifkin MD. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 1997;7:161-163.
19. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003;227:371-377.
20. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 1989;3:96-99.
21. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004;52:78-83.